US CDC publishes guidelines on monkeypox vaccine. Details here
The U.S. Centers for Disease Control and Prevention (CDC) on Friday published recommendations by its group of independent experts on a smallpox vaccine that limit its use to only people who work closely with viruses such as monkeypox.
The Jynneos vaccine, made by Bavarian Nordic, will be available for certain healthcare workers and laboratory personnel at a time when monkeypox infections has spread in Europe, United States and beyond.
The vaccine was approved in the United States in 2019 to prevent smallpox and monkeypox in high risk adults aged 18 and older.
CDC officials earlier this week said they were in the process of releasing some doses of the Jynneos vaccine for people in contact with known monkeypox patients.
Officials said there were over 100 million doses of an older smallpox vaccine called ACAM2000, made by Emergent BioSolutions , which has significant side effects.
Monkeypox is a mild viral infection that is endemic in certain parts of Africa, but the recent outbreak in countries where the virus doesn't usually spread has raised concerns.
So far, there are about 300 confirmed or suspected cases in around 20 countries where the virus was not previously circulating. The World Health Organization has called for quick action from countries to contain the Monkeypox spread.
The CDC said its experts' recommendations are meant for clinical laboratory personnel performing diagnostic tests for orthopoxviruses such as smallpox and monkeypox, laboratory people doing research on the viruses and healthcare workers who administer the ACAM2000 vaccine or care for patients infected with orthopoxviruses.
The publication of the vote by the CDC's Advisory Committee on Immunization Practices, which took place in November last year, formalizes the recommendations.
Both ACAM2000 and Jynneos are available for prevention of orthopoxvirus infections among at-risk people, the CDC said on Friday.
The Friday night ruling stopped a three-day-old order by a Houston judge who said clinics could resume abortions up to six weeks into pregnancy. The following day, the American Civil Liberties Union said it doubted that any abortions were now being provided in a state of nearly 30 million people.
"If our systems identify that someone has visited one of these places, we will delete these entries from Location History soon after they visit," Jen Fitzpatrick, a senior vice president at Google, wrote in a blog post. "This change will take effect in the coming weeks."
Two Indo-Canadian academics, working on research to advance the betterment of mankind, have been honoured with one of the country's most prestigious awards, the Order of Canada. Their names were in the list published by the office of the governor-general of Canada Mary Simon. Both have been invested (as the bestowal of the awards is described) into the Order as a Member. They are professors Ajay Agrawal and Parminder Raina.
The world's richest person, Elon Musk, has not tweeted in about 10 days and it can't go unnoticed. The 51-year-old business tycoon has 100 million followers on the microblogging site, which he is planning to buy. Since April, he has been making headlines for the $44 billion deal and his comments and concerns about the presence of a large number of fake accounts on Twitter.
The Taliban's reclusive supreme leader Haibatullah Akhundzada joined a large gathering of nationwide religious leaders in Kabul on Friday, the state news agency said, adding he would give a speech. The Taliban's state-run Bakhtar News Agency confirmed the reclusive leader, who is based in the southern city of Kandahar, was attending the meeting of more than 3,000 male participants from around the country, aimed at discussing issues of national unity.